Patents by Inventor Manuel Dauchez

Manuel Dauchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonist peptide of the bond between CD47 and a protein belonging to the thrombospondin family
    Patent number: 9605025
    Abstract: Antagonist peptide of the bond between CD47 and a protein belonging to the thrombospondin family has the sequence S1 R1-R2-R3-S-Q-L-L-K-G-R4-R5-R6 and interacts specifically with the C-terminal end of the TSP, at the site of the bond between the TSP and the CD47 receptor. Interaction between the CD47 receptor and the protein is prevented. The peptide can be used in the context of cancer treatments.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: March 28, 2017
    Assignee: Universite de Reims Champagne Ardenne
    Inventors: Stéphane Dedieu, Nicolas Floquet, Laurent Martiny, Christophe Schneider, Albin Jeanne, Emilie Sick, Manuel Dauchez
  • ANTAGONIST PEPTIDE OF THE BOND BETWEEN CD47 AND A PROTEIN BELONGING TO THE THROMBOSPONDIN FAMILY
    Publication number: 20140296477
    Abstract: Antagonist peptide of the bond between CD47 and a protein belonging to the thrombospondin family has the sequence S1 R1-R2-R3-S-Q-L-L-K-G-R4-R5-R6 and interacts specifically with the C-terminal end of the TSP, at the site of the bond between the TSP and the CD47 receptor. Interaction between the CD47 receptor and the protein is prevented. The peptide can be used in the context of cancer treatments.
    Type: Application
    Filed: July 6, 2012
    Publication date: October 2, 2014
    Inventors: Stéphane Dedieu, Nicolas Floquet, Laurent Martiny, Christophe Schneider, Albin Jeanne, Emilie Sick, Manuel Dauchez